You are here

Epanova

JPM: With Vascepa's U.S. expansion rolling, Amarin CEO holds off partner offers in EU

Fierce Pharma

Thu, 01/16/20 - 11:06 pm

AstraZeneca's Epanova flunks key heart risk trial, giving Amarin's rival Vascepa a leg up

Fierce Pharma

Mon, 01/13/20 - 11:01 am

clinical trials

Biotech vet grabs AstraZeneca drug, $26M to start building a new cardio biotech

Fierce Biotech

Thu, 02/18/16 - 05:39 pm

Astra gets lift in Pfizer fight as U.S. okays heart pill

Reuters

Tue, 05/6/14 - 09:11 am

Big Pharma's Big Plans for New Fish Oil Drug

Motley Fool

Sat, 09/21/13 - 10:31 am

AstraZeneca says FDA accepts application for Epanova

The Fly on the Wall

Wed, 09/18/13 - 08:46 am

hypertriglyceridemia

Amarin Shares Move Higher on Competing Fish Oil Data

TheStreet.com

Thu, 04/26/12 - 10:50 am